Fey E G, Penman S
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.
Dev Biol (N Y 1985). 1986;3:81-100.
The dramatic changes in morphology induced by nanomolar doses of tumor-promoting agents, especially in epithelial cells, have been noted previously (Driedger and Blumberg, 1980; Rifkin et al., 1979; Croop et al., 1980; Phaire-Washington et al., 1980; Ohuchi and Levine, 1980; Ojakian, 1981; Fey and Penman, 1984). This chapter shows the effect of the tumor promoter TPA on the underlying skeletal framework, which is involved in the maintenance of both cell and epithelial tissue morphology. It should be emphasized, however, that similar results are obtained for all the tumor promoters as well as for the complete, ultimate carcinogens examined so far. The organization of the cytoskeletal elements involved in these morphological changes is faithfully retained during the fractionation procedure employed here, as is evident from SEM and TEM analysis of Triton-extracted cells. A number of promoting agents have been compared, and the degree of disorganization viewed in these whole mounts appears to parallel the potency of the promoting agents as measured by other assays (Fey and Penman, 1984). Also, the inactive analogues of phorbol ester have no effect on cell structure (Rifkin et al., 1979; Ojakian, 1981; Fey and Penman, 1984). We suggest that the effect of TPA on the cytoskeleton occurs early as compared with many of the commonly studied biochemical responses and may indeed underlie many of the previously described cellular response to promoting agents, such as mitogenic stimulation. TPA-induced alterations in NM-IF scaffold occur in the absence of both protein and RNA synthesis (Fey and Penman, 1984). By contrast, plasminogen activator, stimulated by TPA (Wigler and Weinstein, 1976), is completely blocked by pretreatment with both cycloheximide and actinomycin D (Weinstein et al., 1977; Ojakian, 1981). Ornithine decarboxylase, another enzyme that is rapidly induced by tumor promoters, is inhibited by both cycloheximide and actinomycin D in the presence of TPA (O'Brien, 1976). Thus two of the early biochemical markers for tumor-promoter activity are separable from the induction of cytoskeletal alterations by TPA. One of the most striking features of the response to promoting agents is the adoption of the transformed phenotype, in which cells lose growth control and cease being organized into meaningful tissue structure. The alteration of desmosomal and junctional associations and the concomitant change in cytokeratin organization are clearly related to the breakdown of epithelial organization. The phenotype is completely reversible although it takes about 3 days for the mode line to reestablish normal morphology (data not shown).(ABSTRACT TRUNCATED AT 400 WORDS)
纳摩尔剂量的促癌剂所诱导的形态学显著变化,尤其是在上皮细胞中,此前已有报道(德雷杰和布隆伯格,1980年;里夫金等人,1979年;克鲁普等人,1980年;费尔-华盛顿等人,1980年;大内和莱文,1980年;奥贾基安,1981年;费伊和彭曼,1984年)。本章展示了肿瘤促进剂佛波酯(TPA)对基础骨骼框架的影响,该框架参与细胞和上皮组织形态的维持。然而,应当强调的是,对于所有已检测的肿瘤促进剂以及完全致癌物,都能得到类似的结果。在本文所采用的分级分离过程中,参与这些形态变化的细胞骨架成分的组织被如实地保留下来,从经曲拉通提取的细胞的扫描电子显微镜(SEM)和透射电子显微镜(TEM)分析中可以明显看出。已对多种促进剂进行了比较,在这些整装标本中观察到的紊乱程度似乎与通过其他检测方法测得的促进剂效力平行(费伊和彭曼,1984年)。此外,佛波酯的无活性类似物对细胞结构没有影响(里夫金等人,1979年;奥贾基安,1981年;费伊和彭曼,1984年)。我们认为,与许多常见的生化反应相比,TPA对细胞骨架的作用发生得较早,并且可能确实是许多先前描述的细胞对促进剂的反应(如促有丝分裂刺激)的基础。TPA诱导的中间丝-中间纤维(NM-IF)支架改变发生在蛋白质和RNA合成均不存在的情况下(费伊和彭曼,1984年)。相比之下,由TPA刺激产生的纤溶酶原激活剂(维格勒和温斯坦,1976年),在先用环己酰亚胺和放线菌素D预处理后会被完全阻断(温斯坦等人,1977年;奥贾基安,1981年)。鸟氨酸脱羧酶是另一种被肿瘤促进剂快速诱导的酶,在TPA存在的情况下,它会被环己酰亚胺和放线菌素D抑制(奥布赖恩,1976年)。因此,肿瘤促进剂活性的两个早期生化标志物与TPA诱导的细胞骨架改变是可分离的。对促进剂反应的最显著特征之一是出现转化表型,在此表型中细胞失去生长控制,不再组织成有意义的组织结构。桥粒和连接关联的改变以及细胞角蛋白组织的相应变化显然与上皮组织的破坏有关。尽管模式细胞系大约需要3天才能重新建立正常形态(数据未显示),但该表型是完全可逆的。(摘要截选至400字)